Retraction Note: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus by Jiangnan Zhao, Meiying Zhu, Hao Jiang, Simen Shen, Xin Su, Yi Shi

Get full text

A Recombinant Genotype I Japanese Encephalitis Virus Expressing a <i>Gaussia</i> Luciferase Gene for Antiviral Drug Screening Assay and Neutralizing Antibodies Detection by Chenxi Li, Xuan Chen, Jingbo Hu, Daoyuan Jiang, Demin Cai, Yanhua Li

Subjects: Get full text

Antiviral Approach to Cytomegalovirus Infection: An Overview of Conventional and Novel Strategies by Paolo Bottino, Lisa Pastrone, Antonio Curtoni, Alessandro Bondi, Francesca Sidoti, Elisa Zanotto, Rossana Cavallo, Paolo Solidoro, Cristina Costa

Subjects: Get full text

Cyclodextrins in Antiviral Therapeutics and Vaccines by Susana Santos Braga, Jéssica S. Barbosa, Nádia E. Santos, Firas El-Saleh, Filipe A. Almeida Paz

Subjects: “…antiviral drugs…”
Get full text

Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review by Srinivasan Prabhu, Subramaniyan Vijayakumar, Pabakaran Praseetha

Subjects: “…antiviral drugs…”
Get full text

Descriptive study of severe hospitalized cases of laboratory-confirmed influenza during five epidemic seasons (2010–2015) by Núria Torner, Ana Martínez, Luca Basile, MMar Mosquera, Andrés Antón, Cristina Rius, M. Rosa Sala, Sofia Minguell, Elsa Plasencia, Mónica Carol, Pere Godoy, Núria Follia, Irene Barrabeig, M. Angeles Marcos, Tomàs Pumarola, Mireia Jané

Subjects: Get full text

Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs) by Waleed Attia Hassan, Sherif I. Kamel, Ibrahim Abdel Naby Mahmoud, Nahed Makhlouf, Mahmoud Moubark, Sahar M. Hassany

“…Objective We aimed to evaluate changes in liver fibrosis, portal hemodynamics and clinical outcomes in patients with chronic HCV-related liver cirrhosis after the achievement of SVR with direct-acting antiviral drugs (DAAs). Patients and methods In our prospective longitudinal study, a total of 100 patients with chronic HCV infection-related liver cirrhosis were recruited, received DAAs, and completed the follow-up period. …”
Get full text

Clinico-laboratory and immunological characteristics of patients with compensated cirrhosis of the liver in the outcome of chronic hepatitis C on the background of treatment with a direct antiviral drug paritrapeprir/ritonavir/ombitasvir/ dasabuvir by L. L. Popova, D. Yu. Konstantinov, Ye. A. Strebkova, S. Yu. Vasiliev, Ye. A. Konstantinova, O. O. Golik, Ye. S. Kindalova, A. F. Novikova

Get full text

Second-Order Scattering Quenching in Fluorescence Spectra of Natural Humates as a Tracer of Formation Stable Supramolecular System for the Delivery of Poorly Soluble Antiviral Drugs on the Example of Mangiferin and Favipiravir by Mariya A. Morozova, Vladimir N. Tumasov, Ilaha V. Kazimova, Tatiana V. Maksimova, Elena V. Uspenskaya, Anton V. Syroeshkin

Subjects: Get full text

T-705-Derived Prodrugs Show High Antiviral Efficacies against a Broad Range of Influenza A Viruses with Synergistic Effects When Combined with Oseltamivir by Benedikt Ganter, Martin Zickler, Johanna Huchting, Matthias Winkler, Anna Lüttjohann, Chris Meier, Gülsah Gabriel, Sebastian Beck

Subjects: Get full text

Antiviral Effects of Animal Toxins: Is There a Way to Drugs? by Yuri Utkin, Andrei Siniavin, Igor Kasheverov, Victor Tsetlin

Subjects: Get full text

The Impacts of Antivirals on the Coronavirus Genome Structure and Subsequent Pathogenicity, Virus Fitness and Antiviral Design by Ching-Hung Lin, Cheng-Yao Yang, Shan-Chia Ou, Meilin Wang, Chen-Yu Lo, Tsung-Lin Tsai, Hung-Yi Wu

Subjects: Get full text

AOP-Based Transformation of Abacavir in Different Environments: Evolution Profile of Descyclopropyl-Abacavir and In Silico Toxicity Assessment of the Main Transformation Products by Eleni Evgenidou, Konstantina Vasilopoulou, Lelouda-Athanasia Koronaiou, George Kyzas, Dimitrios Bikiaris, Dimitra Lambropoulou

Subjects: Get full text

Hypertension related toxicity of chloroquine explains its failure against COVID-19: Based on rat model by Junqi Wang, Junqi Wang, Xian Jing, Xian Jing, Lizhong Hua, Yuling Zheng, Yuling Zheng, Shiheng Hu, Shiheng Hu, Jing Xiao, Jing Xiao, Dawei Guo, Dawei Guo, Wenda Wu, Wenda Wu, Hui Ji, Hui Ji, Lin Peng, Lin Peng, Shanxiang Jiang, Shanxiang Jiang, Xiuge Gao, Xiuge Gao

Subjects: Get full text

Recapitulation of the Powassan virus life cycle in cell culture by Jingwei Song, Jiayao Hong, Chen Yang, Yu Zhang, Zhuoyang Li, Peifeng He, Qiang Ding

Subjects: Get full text

CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge by Choongho Lee

Subjects: Get full text

Mathematical processing of absorption as green smart spectrophotometric methods for concurrent assay of hepatitis C antiviral drugs, Sofosbuvir and Simeprevir: application to combined pharmaceutical dosage forms and evaluation of the method greenness by Sayed M. Derayea, Ahmed A. Abu-hassan, Ahmed A. Hamad, Walid E. Eltoukhi, Amal E. Hamad, Bassam Shaaban Mohammed

Get full text

Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD by Thamer A. Bouback, Sushil Pokhrel, Abdulaziz Albeshri, Amal Mohammed Aljohani, Abdus Samad, Rahat Alam, Md Saddam Hossen, Khalid Al-Ghamdi, Md. Enamul Kabir Talukder, Foysal Ahammad, Ishtiaq Qadri, Jesus Simal-Gandara

“…Blocking the entry by targeting the S1-NTD of the virus can facilitate the development of effective antiviral drug candidates against the pathogen. Therefore, the study has been designed to identify effective antiviral drug candidates against the MERS-CoV by targeting S1-NTD. …”
Get full text

Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development by Imprachim, N, Yosaatmadja, Y, Newman, JA

Preventing monkeypox outbreaks: Focus on diagnosis, care, treatment, and vaccination by Moslem Ghaseminia

Subjects: Get full text